Synaptojanin 1 Protein

Synaptojanin 1 Protein

Introduction

Synaptojanin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@cremona1999]
<table> [@mani2007]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">Synaptojanin 1</th></tr>
<tr><td><b>Gene Symbol</b></td><td>[SYNJ1](/genes/synj1)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[O43426](https://www.uniprot.org/uniprotkb/O43426/entry)</td></tr>
<tr><td><b>PDB ID</b></td><td>6YUN, 6YUP</td></tr>
<tr><td><b>Molecular Weight</b></td><td>173 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Presynaptic terminal, cytosol</td></tr>
<tr><td><b>Protein Family</b></td><td>Polyphosphoinositide phosphatase family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">41 edges</a></td>
</tr>
</table>
</div>

Overview

...

Synaptojanin 1 Protein

Introduction

Synaptojanin 1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@cremona1999]
<table> [@mani2007]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">Synaptojanin 1</th></tr>
<tr><td><b>Gene Symbol</b></td><td>[SYNJ1](/genes/synj1)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[O43426](https://www.uniprot.org/uniprotkb/O43426/entry)</td></tr>
<tr><td><b>PDB ID</b></td><td>6YUN, 6YUP</td></tr>
<tr><td><b>Molecular Weight</b></td><td>173 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Presynaptic terminal, cytosol</td></tr>
<tr><td><b>Protein Family</b></td><td>Polyphosphoinositide phosphatase family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">41 edges</a></td>
</tr>
</table>
</div>

Overview

Synaptojanin 1 (SYNJ1) is a phosphoinositide phosphatase critical for synaptic vesicle endocytosis and recycling in [neurons](/entities/neurons). It is encoded by the [SYNJ1](/proteins/synj1-protein) gene on chromosome 21q22.11 and plays essential roles in regulating phosphoinositide metabolism at the synapse[@mcintire2012]. Mutations in SYNJ1 have been linked to early-onset Parkinson's disease with epilepsy, making it a gene of significant interest in neurodegenerative disease research.

Normal Function

Synaptojanin 1 is a presynaptic phosphoinositide phosphatase that functions in synaptic vesicle endocytosis and recycling. It contains multiple domains that enable its diverse functions:

Domain Structure

• N-terminal Sac1 domain: Phosphatase domain with broad specificity for phosphoinositides
• Central Sac3 domain: Additional phosphatase activity
• C-terminal proline-rich region: Interactions with endocytic proteins via SH3 domains

Role in Synaptic Vesicle Cycling

Synaptojanin 1 participates in several key steps of synaptic vesicle recycling[@cremona1999]:

Clathrin uncoating: Dephosphorylates PI(4,5)P2 to PI4P, facilitating clathrin coat dissociation

Membrane remodeling: Regulates phosphoinositide composition of synaptic membranes

Endophilin recruitment: Works with endophilins to deform the presynaptic membrane

Synaptic vesicle reformation: Essential for regenerating fusion-competent synaptic vesicles

Phosphoinositide Regulation

Synaptojanin 1 dephosphorylates:

• PI(4,5)P2 → PI4P
• PI(3,4,5)P3 → PI(3,4)P2
• PI(3,5)P2 → PI3P

This regulation controls membrane identity and trafficking pathways at the synapse.

Structure

Synaptojanin 1 has a complex multi-domain structure:

• Sac1 domain (residues 1-500): Catalytic core with lipid phosphatase activity
• Sac3 domain (residues 650-1100): Additional regulatory phosphatase domain
• PRD (residues 1100-1500): Proline-rich region for protein-protein interactions
• C-terminal region: Autoinhibitory sequences

Crystal structures of the Sac domains have revealed the catalytic mechanism and substrate recognition[@mani2007].

Expression Pattern

Brain Regional Distribution

SYNJ1 is highly expressed in:

• Cerebral [cortex](/brain-regions/cortex) - All layers, particularly layer 5 pyramidal neurons
• [Hippocampus](/brain-regions/hippocampus) - CA3 region and dentate gyrus
• Basal ganglia - Striatum (medium spiny neurons)
• Cerebellum - Purkinje cells
• Brainstem - Pontine nuclei and inferior olive

Cellular Localization

• Presynaptic terminals: Highest concentration at active zones
• Synaptic vesicles: Associated with vesicle membranes
• Endocytic zones: Colocalization with clathrin and dynamin
• Cytosol: Soluble fraction

Disease Associations

Parkinson's Disease (PD)

SYNJ1 mutations cause autosomal recessive early-onset PD with epilepsy:

• PARK20 locus: SYNJ1 mutations identified in families with early-onset PD
• Phenotype: Onset before age 20, parkinsonism, seizures, cognitive decline
• Pathogenic mechanisms: Impaired synaptic vesicle endocytosis, [alpha-synuclein](/mechanisms/alpha-synuclein) interactions[^4]

Epilepsy

• SYNJ1 mutations associated with early-onset epileptic encephalopathy
• Dysregulated phosphoinositide signaling affects neuronal excitability
• Interaction with voltage-gated calcium channels

Alzheimer's Disease

• Altered SYNJ1 expression in AD brain
• Phosphoinositide dysregulation in AD neurons
• Potential role in [amyloid precursor protein](/entities/app-protein) (APP) processing

Huntington's Disease

• SYNJ1 involvement in vesicular trafficking
• Mutant [huntingtin](/proteins/huntingtin-protein) affects synaptic function
• Potential therapeutic target

Therapeutic Targeting

Small Molecule Inhibitors

| Agent | Target | Development Status | Indication |
|-------|--------|-------------------|------------|
| PI(4,5)P2 analogs | Sac domain | Preclinical | SYNJ1 modulation |
| Allosteric inhibitors | PRD | Discovery | PD |
| Phosphatase activators | Sac1 | Preclinical | Neuroprotection |

Gene Therapy Approaches

• AAV-SYNJ1: Wild-type SYNJ1 delivery for loss-of-function
• RNAi: Knockdown of toxic mutant expression
• CRISPR: Gene correction of pathogenic variants

Therapeutic Strategies

Phosphoinositide modulation: Restore PI(4,5)P2 homeostasis

Synaptic protection: Maintain vesicle cycling

[Alpha-synuclein](/proteins/alpha-synuclein) clearance: Reduce pathological aggregation

Research Directions

Biomarkers

• SYNJ1 expression in CSF as synaptic marker
• Phosphoinositide levels in patient-derived neurons
• PET tracers for synaptic density

Patient-Derived Models

• iPSC-derived neurons from SYNJ1 mutation carriers
• Cerebral organoids showing synaptic deficits
• Xenografts for drug testing

Animal Models

• Synj1 knockout mice: Embryonic lethal - essential for viability
• Conditional knockout: Brain-specific deletion studies
• heterozygous mice: Show age-related synaptic deficits
• Zebrafish models: Morphants show neurological phenotypes

Background

The study of Synaptojanin 1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• SYNJ1 Gene
• [Synaptic Vesicle Cycling Pathway](/mechanisms/synaptic-vesicle-cycling-pathway)
• Phosphoinositide Signaling Pathway
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Early-Onset Parkinson Disease with Epilepsy
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)

External Links

• [UniProt: O43426](https://www.uniprot.org/uniprotkb/O43426/entry)
• [PDB: Synaptojanin 1](https://www.rcsb.org/structure/6YUN)
• [NCBI Gene: SYNJ1](https://www.ncbi.nlm.nih.gov/gene/8867)
• [GWAS Catalog: SYNJ1](https://www.ebi.ac.uk/gwas/genes/SYNJ1)

References

McIntire LB, et al, Identification of SYNJ1 variants associated with early-onset Parkinson disease and epilepsy (2012)

Cremona O, et al, Essential role of phosphoinositide metabolism in synaptic vesicle recycling (1999)

Mani M, et al, The dual phosphatase activity of synaptojanin1 is required for both efficient clathrin-mediated endocytosis and recycling (2007)